Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 2/20 | 0.49 |
| ▸ | CREB1 | P16220 | 2/20 | 0.48 |
| ▸ | EGFR | P00533 | 15/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17138137 | 0.81 | BCHE (0.58) | ABCB1KDM4EALDH1A1CYP3A4HPGD | |
| SCHEMBL17138215 | 0.78 | ADORA3 (0.60) | ABCB1EGFRKDM4EALDH1A1CYP1A2 | |
| SCHEMBL433000 | 0.73 | CREB1 (0.60) | ABCB1CREB1KDM4EPOLBABCG2 | |
| SCHEMBL12792821 | 0.72 | ABCB1 (0.66) | ABCB1CREB1EGFRKDM4EALDH1A1 | |
| SCHEMBL17938465 | 0.72 | CA2 (0.56) | KDM4EALDH1A1CYP3A4 | |
| SCHEMBL20519779 | 0.71 | KDM4E (0.47) | KDM4EALDH1A1CYP3A4 | |
| SCHEMBL971180 | 0.71 | CREB1 (0.66) | ABCB1CREB1KDM4EALDH1A1CYP3A4 | |
| SCHEMBL17138145 | 0.71 | ADORA3 (0.51) | ABCB1KDM4EALDH1A1CYP3A4ABCG2 | |
| SCHEMBL973627 | 0.71 | CREB1 (0.74) | ABCB1CREB1ABCG2 | |
| SCHEMBL17138192 | 0.71 | CA2 (0.51) | KDM4EALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150283051-A1 | DERIVATIVE OF NOVEL POLYHYDROXY AROMATIC COMPOUND AND USE THEREOF | RNS CO.,LTD. (KR) | 2015-10-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150283051-A1 | DERIVATIVE OF NOVEL POLYHYDROXY AROMATIC COMPOUND AND USE THEREOF | HRH3, CBR3, H1-0 | ABCB1 4482/4885CREB1 589/4885EGFR 2318/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.